Amicus Therapeutics, Inc. (FOLD)

Amicus Therapeutics Revenue

Amicus Therapeutics had revenue of $141.52M in the quarter ending September 30, 2024, with 36.73% growth. This brings the company's revenue in the last twelve months to $493.67M, up 32.58% year-over-year. In the year 2023, Amicus Therapeutics had annual revenue of $399.36M with 21.30% growth.

• Revenue (ttm): $493.67M
• Revenue Growth: +32.58%
• P/S Ratio: 5.91
• Revenue / Employee: $954,876
• Employees: 517
• Market Cap: 2.88B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	399.36M	70.12M	21.30%
Dec 31, 2022	329.23M	23.72M	7.76%
Dec 31, 2021	305.51M	44.63M	17.11%
Dec 31, 2020	260.89M	78.65M	43.16%
Dec 31, 2019	182.24M	90.99M	99.72%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.